ArticleNeuro-oncology2024

High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma.

Leilei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.